Rapid Evolution in Colorectal Cancer: Therapy Now and Over the Next Five Years

Rapid Evolution in Colorectal Cancer: Therapy Now and Over the Next Five Years Aimery de Gramont Oncologist 2005; 10: 4-8 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in gastrointestinal cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Discuss the public health importance and natural history of colorectal cancer. Describe how treatments developed in the context of clinical trials have changed the prognosis of this disease. Explain the potential impact of clinical trials on future treatment guidelines. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Nov. 04, 2005 Most Recent Review: Nov. 04, 2005* Most Recent Update: Nov. 04, 2005 Date Credit Expires: Nov. 04, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.